Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Amarin Common Stock Net 2010-2025 | AMRN

Amarin common stock net from 2010 to 2025. Common stock net can be defined as the value of common equity ownership.
  
Amarin Annual Common Stock Net
(Millions of US $)
2024 $305
2023 $303
2022 $299
2021 $294
2020 $290
2019 $269
2018 $247
2017 $209
2016 $207
2015 $150
2014 $143
2013 $141
2012 $125
2011 $113
2010 $90
2009 $84
Amarin Quarterly Common Stock Net
(Millions of US $)
2025-06-30 $309
2025-03-31 $308
2024-12-31 $305
2024-09-30 $305
2024-06-30 $305
2024-03-31 $305
2023-12-31 $303
2023-09-30 $302
2023-06-30 $302
2023-03-31 $301
2022-12-31 $299
2022-09-30 $299
2022-06-30 $295
2022-03-31 $294
2021-12-31 $294
2021-09-30 $293
2021-06-30 $293
2021-03-31 $292
2020-12-31 $290
2020-09-30 $288
2020-06-30 $286
2020-03-31 $271
2019-12-31 $269
2019-09-30 $267
2019-06-30 $251
2019-03-31 $250
2018-12-31 $247
2018-09-30 $233
2018-06-30 $226
2018-03-31 $225
2017-12-31 $209
2017-09-30 $209
2017-06-30 $209
2017-03-31 $208
2016-12-31 $207
2016-09-30 $207
2016-06-30 $151
2016-03-31 $151
2015-12-31 $150
2015-09-30 $150
2015-06-30 $150
2015-03-31 $145
2014-12-31 $143
2014-09-30 $143
2014-06-30 $142
2014-03-31 $142
2013-12-31 $141
2013-09-30 $141
2013-06-30 $125
2013-03-31 $125
2012-12-31 $125
2012-09-30 $124
2012-06-30 $123
2012-03-31 $114
2011-12-31 $113
2011-09-30 $113
2011-06-30 $111
2011-03-31 $106
2010-12-31 $90
2010-09-30 $0
2010-06-30 $0
2010-03-31 $0
2009-12-31 $84
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.309B $0.229B
Amarin Corporation plc is a commercial-stage pharmaceutical company focused on developing therapies, especially based on omega-3 fatty acid for treating cardiovascular diseases. The company's sole marketed drug, Vascepa (icosapent ethyl) is approved in the United States as an adjunct to diet for treating severe hypertriglyceridemia or elevated triglyceride levels. The FDA approved Vascepa to reduce cardiovascular risk in patients with persistent elevated triglycerides on statin therapy for LDL-C. The drug received approval for both indications in Europe under the tradename of Vazkepa. It has initiated various promotional activities and direct-to-consumer programs as well as expanded its salesforce to support promotion of Vascepa's expanded label. A generic version of Vascepa has been launched for elevated TG levels.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $229.716B 16.76
Amgen (AMGN) United States $153.482B 13.07
Gilead Sciences (GILD) United States $149.480B 15.56
Vertex Pharmaceuticals (VRTX) United States $96.008B 24.75
Bristol Myers Squibb (BMY) United States $93.488B 6.82
CSL (CSLLY) Australia $83.188B 0.00
GSK (GSK) United Kingdom $76.897B 8.94
Regeneron Pharmaceuticals (REGN) United States $57.863B 14.08
Alnylam Pharmaceuticals (ALNY) United States $57.019B 0.00
Argenex SE (ARGX) Netherlands $39.101B 68.77
BioNTech SE (BNTX) Germany $26.266B 0.00
Insmed (INSM) United States $23.862B 0.00
Royalty Pharma (RPRX) United States $20.347B 8.24
Biogen (BIIB) United States $18.767B 7.99
Incyte (INCY) United States $15.464B 19.70
Illumina (ILMN) United States $14.568B 22.78
Genmab (GNMSF) Denmark $14.293B 12.66
Genmab (GMAB) Denmark $13.524B 12.33
Ascendis Pharma (ASND) Denmark $11.984B 0.00
BioMarin Pharmaceutical (BMRN) United States $10.906B 15.39
QIAGEN (QGEN) Netherlands $10.672B 20.46
Swedish Orphan Biovitrum (BIOVF) Sweden $10.605B 23.46
Exelixis (EXEL) United States $10.071B 18.16
Moderna (MRNA) United States $9.910B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $8.959B 0.00
Bio-Techne Corp (TECH) United States $7.862B 28.99
Halozyme Therapeutics (HALO) United States $7.749B 12.94
Exact Sciences (EXAS) United States $7.745B 0.00
Roivant Sciences (ROIV) United Kingdom $7.593B 0.00
Guardant Health (GH) United States $6.834B 0.00
Anbio Biotechnology (NNNN) Germany $6.767B 0.00
Bio-Rad Laboratories (BIO.B) United States $6.723B 24.56
Jazz Pharmaceuticals (JAZZ) Ireland $6.718B 35.84
Legend Biotech (LEGN) United States $6.660B 0.00
Revolution Medicines (RVMD) United States $6.487B 0.00
Repligen (RGEN) United States $6.294B 68.64
Rhythm Pharmaceuticals (RYTM) United States $6.264B 0.00
Avidity Biosciences (RNA) United States $5.890B 0.00
Nuvalent (NUVL) United States $5.382B 0.00
Abivax SA (ABVX) France $5.213B 0.00
Axsome Therapeutics (AXSM) United States $5.188B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.040B 0.00
Merus (MRUS) Netherlands $4.886B 0.00
Alkermes (ALKS) Ireland $4.381B 12.17
Viking Therapeutics (VKTX) United States $4.294B 0.00
ACADIA Pharmaceuticals (ACAD) United States $4.187B 38.78
TG Therapeutics (TGTX) United States $4.187B 71.32
Krystal Biotech (KRYS) United States $3.981B 27.95
Cytokinetics (CYTK) United States $3.976B 0.00
ADMA Biologics Inc (ADMA) United States $3.910B 28.24
Akero Therapeutics (AKRO) United States $3.862B 0.00
Vaxcyte (PCVX) United States $3.852B 0.00
Zai Lab (ZLAB) United States $3.850B 0.00
Arcellx (ACLX) United States $3.832B 0.00
Jyong Biotech (MENS) Taiwan $3.768B 0.00
Ascentage Pharma Group - (AAPG) China $3.722B 0.00
Telix Pharmaceuticals (TLX) Australia $3.685B 0.00
Zealand Pharma (ZLDPF) Denmark $3.561B 0.00
PTC Therapeutics (PTCT) United States $3.440B 5.71
MoonLake Immunotherapeutics (MLTX) Switzerland $3.417B 0.00
Protagonist Therapeutics (PTGX) United States $3.344B 76.79
Mirum Pharmaceuticals (MIRM) United States $3.309B 0.00
Metsera (MTSR) United States $3.166B 0.00
Scholar Rock Holding (SRRK) United States $3.024B 0.00
Apellis Pharmaceuticals (APLS) United States $3.012B 0.00
Bavarian Nordic (BVNRY) Denmark $2.910B 15.38
Ligand Pharmaceuticals (LGND) United States $2.836B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.700B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.640B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.617B 0.00
Alvotech (ALVO) Luxembourg $2.569B 14.69
Immunovant (IMVT) United States $2.525B 0.00
Kymera Therapeutics (KYMR) United States $2.454B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.426B 818.50
Arrowhead Pharmaceuticals (ARWR) United States $2.379B 0.00
ImmunityBio (IBRX) United States $2.335B 0.00
Belite Bio (BLTE) United States $2.213B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.150B 0.00
Tarsus Pharmaceuticals (TARS) United States $2.114B 0.00
Amicus Therapeutics (FOLD) United States $2.051B 0.00
Agios Pharmaceuticals (AGIO) United States $2.038B 0.00
Disc Medicine (IRON) United States $2.029B 0.00
Denali Therapeutics (DNLI) United States $2.022B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.002B 11.23
IDEAYA Biosciences (IDYA) United States $2.002B 0.00
Mesoblast (MESO) Australia $1.882B 0.00
Adaptive Biotechnologies (ADPT) United States $1.850B 0.00
ANI Pharmaceuticals (ANIP) United States $1.839B 16.51
CG Oncology (CGON) United States $1.826B 0.00
Celcuity (CELC) United States $1.816B 0.00
Liquidia Technologies (LQDA) United States $1.812B 0.00
Vericel (VCEL) United States $1.788B 295.25
Sarepta Therapeutics (SRPT) United States $1.753B 0.00
Beam Therapeutics (BEAM) United States $1.736B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.701B 0.00
Certara (CERT) United States $1.682B 30.79
Twist Bioscience (TWST) United States $1.668B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.602B 0.00
Apogee Therapeutics (APGE) United States $1.596B 0.00
Cidara Therapeutics (CDTX) United States $1.572B 0.00
Travere Therapeutics (TVTX) United States $1.540B 0.00
Viridian Therapeutics (VRDN) United States $1.379B 0.00
Biohaven (BHVN) United States $1.369B 0.00
Edgewise Therapeutics (EWTX) United States $1.368B 0.00
Janux Therapeutics (JANX) United States $1.362B 0.00
AbCellera Biologics (ABCL) Canada $1.345B 0.00
Celldex Therapeutics (CLDX) United States $1.329B 0.00
Novavax (NVAX) United States $1.304B 3.52
89BIO (ETNB) United States $1.301B 0.00
WAVE Life Sciences (WVE) Singapore $1.290B 0.00
Vera Therapeutics (VERA) United States $1.286B 0.00
Cogent Biosciences (COGT) United States $1.244B 0.00
Dynavax Technologies (DVAX) United States $1.228B 52.38
NovoCure (NVCR) Jersey $1.219B 0.00
CureVac (CVAC) Germany $1.218B 5.90
GRAIL (GRAL) United States $1.176B 0.00
Intellia Therapeutics (NTLA) United States $1.153B 0.00
Pacira BioSciences (PCRX) United States $1.132B 11.99
LENZ Therapeutics (LENZ) United States $1.106B 0.00
Pharvaris (PHVS) Netherlands $1.090B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.078B 0.00
MannKind (MNKD) United States $1.049B 31.09
MiMedx (MDXG) United States $1.042B 23.47
Structure Therapeutics (GPCR) United States $1.009B 0.00
Arcus Biosciences (RCUS) United States $0.975B 0.00
Anavex Life Sciences (AVXL) United States $0.969B 0.00
Praxis Precision Medicines (PRAX) United States $0.946B 0.00
Zymeworks (ZYME) United States $0.935B 0.00
Spyre Therapeutics (SYRE) United States $0.921B 0.00
Upstream Bio (UPB) United States $0.894B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.892B 0.00
Trevi Therapeutics (TRVI) United States $0.892B 0.00
Sionna Therapeutics (SION) United States $0.884B 0.00
Geron (GERN) United States $0.868B 0.00
Mineralys Therapeutics (MLYS) United States $0.860B 0.00
Urogen Pharma (URGN) United States $0.844B 0.00
Immunome (IMNM) United States $0.841B 0.00
Pharming Group (PHAR) Netherlands $0.829B 0.00
Oculis Holding AG (OCS) Switzerland $0.785B 0.00
Oric Pharmaceuticals (ORIC) United States $0.784B 0.00
Niagen Bioscience (NAGE) United States $0.783B 75.54
Pharming Group (PHGUF) Netherlands $0.778B 0.00
UniQure (QURE) Netherlands $0.775B 0.00
Immatics (IMTX) Germany $0.771B 0.00
Nuvation Bio (NUVB) United States $0.762B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.761B 0.00
NeoGenomics (NEO) United States $0.752B 0.00
CorMedix Inc (CRMD) United States $0.752B 13.43
BGM Group (BGM) China $0.740B 0.00
Nurix Therapeutics (NRIX) United States $0.738B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.729B 0.00
Stoke Therapeutics (STOK) United States $0.718B 16.66
Tango Therapeutics (TNGX) United States $0.713B 0.00
Iovance Biotherapeutics (IOVA) United States $0.713B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.708B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.696B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.668B 0.00
Gyre Therapeutics (GYRE) United States $0.663B 141.40
Sana Biotechnology (SANA) United States $0.658B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.657B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Arbutus Biopharma (ABUS) United States $0.642B 0.00
MeiraGTx Holdings (MGTX) United States $0.630B 0.00
Zenas BioPharma (ZBIO) United States $0.624B 0.00
GH Research (GHRS) Ireland $0.614B 0.00
Dianthus Therapeutics (DNTH) United States $0.608B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.604B 0.00
ArriVent BioPharma (AVBP) United States $0.595B 0.00
Vir Biotechnology (VIR) United States $0.595B 0.00
Maze Therapeutics (MAZE) United States $0.590B 0.00
Fortrea Holdings (FTRE) United States $0.580B 10.31
Myriad Genetics (MYGN) United States $0.576B 0.00
AnaptysBio (ANAB) United States $0.560B 0.00
Castle Biosciences (CSTL) United States $0.556B 54.74
Terns Pharmaceuticals (TERN) United States $0.551B 0.00
ATyr Pharma (ATYR) United States $0.550B 0.00
Bicara Therapeutics (BCAX) United States $0.545B 0.00
Keros Therapeutics (KROS) United States $0.542B 43.06
Tyra Biosciences (TYRA) United States $0.536B 0.00
Opthea (OPT) Australia $0.525B 0.00
Rapport Therapeutics (RAPP) United States $0.521B 0.00
Rezolute (RZLT) United States $0.517B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.517B 0.00
Precigen (PGEN) United States $0.514B 0.00
Septerna (SEPN) United States $0.512B 0.00
Arvinas (ARVN) United States $0.483B 0.00
Cytek Biosciences (CTKB) United States $0.482B 0.00
Kura Oncology (KURA) United States $0.481B 0.00
Verastem (VSTM) United States $0.474B 0.00
Prime Medicine (PRME) United States $0.472B 0.00
Solid Biosciences (SLDB) United States $0.471B 0.00
Compass Therapeutics (CMPX) United States $0.462B 0.00
Palvella Therapeutics (PVLA) United States $0.461B 0.00
Eton Pharmaceuticals (ETON) United States $0.457B 0.00
ITeos Therapeutics (ITOS) United States $0.447B 0.00
Emergent Biosolutions (EBS) United States $0.435B 3.56
Kodiak Sciences (KOD) United States $0.424B 0.00
Kamada (KMDA) Israel $0.422B 25.31
Erasca (ERAS) United States $0.419B 0.00
Cullinan Therapeutics (CGEM) United States $0.419B 0.00
PureTech Health (PRTC) United States $0.414B 0.00
Tectonic Therapeutic (TECX) United States $0.414B 0.00
Prothena (PRTA) Ireland $0.413B 0.00
Gossamer Bio (GOSS) United States $0.395B 0.00
Replimune (REPL) United States $0.390B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.387B 0.00
MBX Biosciences (MBX) United States $0.378B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.378B 0.00
Astria Therapeutics (ATXS) United States $0.377B 0.00
REGENXBIO (RGNX) United States $0.377B 0.00
Absci (ABSI) United States $0.364B 0.00
Northwest Biotherapeutics (NWBO) United States $0.360B 0.00
Aura Biosciences (AURA) United States $0.344B 0.00
Fulcrum Therapeutics (FULC) United States $0.343B 0.00
Inventiva S.A (IVA) France $0.337B 0.00
XOMA Royalty (XOMA) United States $0.326B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.326B 0.00
Abeona Therapeutics (ABEO) United States $0.321B 0.00
I-Mab (IMAB) United States $0.317B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.315B 0.00
Olema Pharmaceuticals (OLMA) United States $0.313B 0.00
Benitec Biopharma (BNTC) United States $0.312B 0.00
Candel Therapeutics (CADL) United States $0.311B 0.00
Inhibrx Biosciences (INBX) United States $0.310B 0.18
Arcturus Therapeutics Holdings (ARCT) United States $0.309B 0.00
Neurogene (NGNE) United States $0.290B 0.00
Cartesian Therapeutics (RNAC) United States $0.289B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.287B 0.00
Ocugen (OCGN) United States $0.287B 0.00
Atea Pharmaceuticals (AVIR) United States $0.279B 0.00
Design Therapeutics (DSGN) United States $0.274B 0.00
Bright Minds Biosciences (DRUG) United States $0.273B 0.00
Humacyte (HUMA) United States $0.271B 0.00
Lifecore Biomedical (LFCR) United States $0.270B 0.00
Sagimet Biosciences (SGMT) United States $0.268B 0.00
DBV Technologies S.A (DBVT) France $0.267B 0.00
Foghorn Therapeutics (FHTX) United States $0.266B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.266B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.259B 11.64
Annexon (ANNX) United States $0.258B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.254B 0.00
Crescent Biopharma (CBIO) United States $0.252B 0.00
Vor Biopharma (VOR) $0.252B 0.00
Prima BioMed (IMMP) Australia $0.250B 0.00
ScPharmaceuticals (SCPH) United States $0.248B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.248B 0.00
Puma Biotechnology (PBYI) United States $0.244B 4.95
Aardvark Therapeutics (AARD) United States $0.242B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.242B 0.00
DiaMedica Therapeutics (DMAC) United States $0.237B 0.00
Alumis (ALMS) United States $0.236B 0.00
Alpha Teknova (TKNO) United States $0.236B 0.00
Neumora Therapeutics (NMRA) United States $0.233B 0.00
Codexis (CDXS) United States $0.232B 0.00
Adherex Technologies (FENC) United States $0.229B 0.00
Tvardi Therapeutics (TVRD) United States $0.226B 0.00
Alector (ALEC) United States $0.226B 0.00
Allogene Therapeutics (ALLO) United States $0.225B 0.00
CARGO Therapeutics (CRGX) United States $0.217B 0.00
Adocia (ADOCY) France $0.216B 0.00
AC Immune (ACIU) Switzerland $0.208B 0.00
Innate Pharma S.A (IPHA) France $0.199B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.199B 0.00
Monopar Therapeutics (MNPR) United States $0.192B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.191B 0.00
Entrada Therapeutics (TRDA) United States $0.191B 0.00
EnGene Holdings (ENGN) Canada $0.189B 0.00
Ventyx Biosciences (VTYX) United States $0.188B 0.00
GENFIT S.A (GNFT) France $0.187B 0.00
CytomX Therapeutics (CTMX) United States $0.186B 4.12
Instil Bio (TIL) United States $0.186B 0.00
Editas Medicine (EDIT) United States $0.184B 0.00
Semper Paratus Acquisition (TVGN) United States $0.180B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.174B 0.00
C4 Therapeutics (CCCC) United States $0.172B 0.00
Voyager Therapeutics (VYGR) United States $0.171B 0.00
BioStem Technologies (BSEM) $0.168B 6.84
Greenwich LifeSciences (GLSI) United States $0.167B 0.00
Contineum Therapeutics (CTNM) United States $0.166B 0.00
Actuate Therapeutics (ACTU) United States $0.164B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.162B 0.00
Alpha Cognition (ACOG) Canada $0.160B 0.00
Caribou Biosciences (CRBU) United States $0.159B 0.00
Rapt Therapeutics (RAPT) United States $0.158B 0.00
Nuvectis Pharma (NVCT) United States $0.156B 0.00
BioAge Labs (BIOA) United States $0.156B 0.00
Cardiff Oncology (CRDF) United States $0.155B 0.00
SELLAS Life Sciences (SLS) United States $0.154B 0.00
Cellectis S.A (CLLS) France $0.147B 0.00
Theratechnologies (THTX) Canada $0.147B 0.00
BioHarvest Sciences (BHST) Canada $0.145B 0.00
Nkarta (NKTX) United States $0.143B 0.00
Elicio Therapeutics (ELTX) United States $0.141B 0.00
MaxCyte (MXCT) United States $0.141B 0.00
Molecular Partners AG (MOLN) Switzerland $0.140B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.139B 0.00
Citius Oncology (CTOR) United States $0.135B 0.00
Kyverna Therapeutics (KYTX) United States $0.134B 0.00
Compugen (CGEN) Israel $0.134B 0.00
TuHURA Biosciences (HURA) United States $0.133B 0.00
Black Diamond Therapeutics (BDTX) United States $0.132B 10.04
Seer (SEER) United States $0.130B 0.00
Seres Therapeutics (MCRB) United States $0.127B 0.00
Genelux (GNLX) United States $0.124B 0.00
Spero Therapeutics (SPRO) United States $0.123B 0.00
Anika Therapeutics (ANIK) United States $0.118B 0.00
OKYO Pharma (OKYO) $0.117B 0.00
Agenus (AGEN) United States $0.117B 0.00
Immuneering (IMRX) United States $0.116B 0.00
Connect Biopharma Holdings (CNTB) United States $0.114B 0.00
Climb Bio (CLYM) United States $0.112B 0.00
Tenaya Therapeutics (TNYA) United States $0.111B 0.00
23andMe Holding (MEHCQ) United States $0.110B 0.00
Scilex Holding (SCLX) United States $0.110B 0.00
Skye Bioscience (SKYE) United States $0.109B 0.00
Adagene (ADAG) China $0.108B 0.00
Fate Therapeutics (FATE) United States $0.107B 0.00
Pliant Therapeutics (PLRX) United States $0.104B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.104B 0.00
HilleVax (HLVX) United States $0.103B 0.00
Coya Therapeutics (COYA) United States $0.103B 0.00
Sangamo Therapeutics (SGMO) United States $0.103B 0.00
Coherus Oncology (CHRS) United States $0.102B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.101B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.097B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.097B 0.00
Zura Bio (ZURA) United States $0.096B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.095B 0.00
Invivyd (IVVD) United States $0.092B 0.00
TScan Therapeutics (TCRX) United States $0.091B 0.00
Nautilus Biotechnology (NAUT) United States $0.091B 0.00
XBiotech (XBIT) United States $0.090B 0.00
CervoMed (CRVO) United States $0.088B 0.00
VistaGen Therapeutics (VTGN) United States $0.087B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.086B 0.00
Entera Bio (ENTX) Israel $0.086B 0.00
Quince Therapeutics (QNCX) United States $0.086B 0.00
Oncolytics Biotech (ONCY) Canada $0.085B 0.00
Immunic (IMUX) United States $0.084B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.083B 0.00
Alto Neuroscience (ANRO) United States $0.083B 0.00
BeyondSpring (BYSI) United States $0.083B 0.00
EXoZymes (EXOZ) United States $0.083B 0.00
Elutia (ELUT) United States $0.081B 0.00
Whitehawk Therapeutics (WHWK) United States $0.080B 0.00
IGM Biosciences (IGMS) United States $0.078B 0.00
Celularity (CELU) United States $0.077B 0.00
Quantum Biopharma (QNTM) Canada $0.076B 0.00
TELA Bio (TELA) United States $0.074B 0.00
Forte Biosciences (FBRX) United States $0.069B 0.00
IO Biotech (IOBT) Denmark $0.069B 0.00
Cabaletta Bio (CABA) United States $0.067B 0.00
Immix Biopharma (IMMX) United States $0.067B 0.00
Repare Therapeutics (RPTX) Canada $0.066B 0.00
Oncobiologics (OTLK) United States $0.066B 0.00
MediciNova (MNOV) United States $0.066B 0.00
Sutro Biopharma (STRO) United States $0.066B 0.00
Genenta Science S.p.A (GNTA) Italy $0.064B 0.00
INmune Bio (INMB) United States $0.064B 0.00
Applied Therapeutics (APLT) United States $0.064B 0.00
Opus Genetics (IRD) United States $0.063B 0.00
Cognition Therapeutics (CGTX) United States $0.063B 0.00
Cue Biopharma (CUE) United States $0.063B 0.00
Artiva Biotherapeutics (ARTV) United States $0.063B 0.00
ZIVO Bioscience (ZIVO) United States $0.062B 0.00
Atara Biotherapeutics (ATRA) United States $0.062B 0.00
Adlai Nortye (ANL) Cayman Islands $0.059B 0.00
ImageneBio (IMA) United States $0.059B 0.00
Biomea Fusion (BMEA) United States $0.057B 0.00
Fortress Biotech (FBIO) United States $0.057B 0.00
Earth Science Tech (ETST) United States $0.056B 0.00
InflaRx (IFRX) Germany $0.055B 0.00
Annovis Bio (ANVS) United States $0.055B 0.00
Werewolf Therapeutics (HOWL) United States $0.053B 0.00
Inovio Pharmaceuticals (INO) United States $0.053B 0.00
Precision BioSciences (DTIL) United States $0.051B 0.00
KALA BIO (KALA) United States $0.051B 0.00
ABVC BioPharma (ABVC) United States $0.050B 0.00
Kalaris Therapeutics (KLRS) United States $0.050B 0.00
Adicet Bio (ACET) United States $0.050B 0.00
VTv Therapeutics (VTVT) United States $0.049B 0.00
PDS Biotechnology (PDSB) United States $0.049B 0.00
MiNK Therapeutics (INKT) United States $0.049B 0.00
Exicure (XCUR) United States $0.048B 0.00
Alterity Therapeutics - (ATHE) Australia $0.047B 0.00
Adverum Biotechnologies (ADVM) United States $0.047B 0.00
Lantern Pharma (LTRN) United States $0.047B 0.00
Aligos Therapeutics (ALGS) United States $0.046B 0.00
Barinthus Biotherapeutics (BRNS) United States $0.046B 0.00
Grace Therapeutics (GRCE) Canada $0.043B 0.00
Renovaro (RENB) United States $0.041B 0.00
RenovoRx (RNXT) United States $0.041B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.040B 0.00
Senti Biosciences (SNTI) United States $0.040B 0.00
Ovid Therapeutics (OVID) United States $0.040B 0.00
Jasper Therapeutics (JSPR) United States $0.040B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.039B 0.00
BioXcel Therapeutics (BTAI) United States $0.039B 0.00
CalciMedica (CALC) United States $0.039B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.038B 0.00
Radiopharm Theranostics - (RADX) Australia $0.037B 0.00
Pluri (PLUR) Israel $0.036B 0.00
Shattuck Labs (STTK) United States $0.035B 0.00
Xilio Therapeutics (XLO) United States $0.035B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.034B 0.00
PepGen (PEPG) United States $0.033B 0.00
ALX Oncology Holdings (ALXO) United States $0.033B 0.00
AN2 Therapeutics (ANTX) United States $0.032B 0.00
Clearside Biomedical (CLSD) United States $0.032B 0.00
Equillium (EQ) United States $0.032B 0.00
Rani Therapeutics Holdings (RANI) United States $0.032B 0.00
Clene (CLNN) United States $0.032B 0.00
Estrella Immunopharma (ESLA) United States $0.031B 0.00
Mersana Therapeutics (MRSN) United States $0.030B 0.00
Kezar Life Sciences (KZR) United States $0.029B 0.00
OnKure Therapeutics (OKUR) United States $0.027B 0.00
CAMP4 Therapeutics (CAMP) United States $0.027B 0.00
Generation Bio (GBIO) United States $0.027B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.027B 0.00
Medicus Pharma (MDCX) United States $0.027B 0.00
Rein Therapeutics (RNTX) United States $0.027B 0.00
Femasys (FEMY) United States $0.025B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.025B 0.00
Boundless Bio (BOLD) United States $0.025B 0.00
Dyadic (DYAI) United States $0.024B 0.00
Tenax Therapeutics (TENX) United States $0.024B 0.00
Lisata Therapeutics (LSTA) United States $0.024B 0.00
FibroBiologics (FBLG) United States $0.023B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.023B 0.00
Cadrenal Therapeutics (CVKD) United States $0.022B 0.00
Q32 Bio (QTTB) United States $0.022B 0.00
Cingulate (CING) United States $0.021B 0.00
BioAtla (BCAB) United States $0.021B 0.00
SAB Biotherapeutics (SABS) United States $0.021B 0.00
Rallybio (RLYB) United States $0.021B 0.00
Promis Neurosciences (PMN) Canada $0.021B 0.00
Curis (CRIS) United States $0.020B 0.00
180 Life Sciences (ATNF) United States $0.020B 0.00
Aytu BioPharma (AYTU) United States $0.020B 0.00
Moleculin Biotech (MBRX) United States $0.019B 0.00
Passage Bio (PASG) United States $0.018B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.018B 0.00
Chemomab Therapeutics (CMMB) Israel $0.018B 0.00
Dare Bioscience (DARE) United States $0.018B 0.00
Imunon (IMNN) United States $0.017B 0.00
LakeShore Biopharma (LSB) China $0.017B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.016B 0.00
Synlogic (SYBX) United States $0.016B 0.00
Lexaria Bioscience (LEXX) Canada $0.016B 0.00
MetaVia (MTVA) United States $0.015B 0.00
Hoth Therapeutics (HOTH) United States $0.015B 0.00
Gelteq (GELS) Australia $0.015B 0.00
Abpro Holdings (ABP) United States $0.015B 0.00
Athira Pharma (ATHA) United States $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.015B 0.00
Beyond Air (XAIR) United States $0.015B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.014B 0.00
Allarity Therapeutics (ALLR) United States $0.014B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.014B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.013B 0.00
Leap Therapeutics (LPTX) United States $0.013B 0.00
NextCure (NXTC) United States $0.013B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
GeoVax Labs (GOVX) United States $0.011B 0.00
Bolt Biotherapeutics (BOLT) United States $0.011B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
Longeveron (LGVN) United States $0.011B 0.00
Synaptogenix (TAOX) United States $0.010B 0.00
Bionano Genomics (BNGO) United States $0.010B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.010B 0.00
IBio (IBIO) United States $0.010B 0.00
Sensei Biotherapeutics (SNSE) United States $0.009B 0.00
Aprea Therapeutics (APRE) United States $0.009B 0.00
Biofrontera (BFRI) United States $0.009B 0.00
Portage Biotech (PRTG) $0.009B 0.00
BioCardia (BCDA) United States $0.009B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
Novogen (KZIA) Australia $0.008B 0.00
X4 Pharmaceuticals (XFOR) United States $0.008B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
Advanced Biomed (ADVB) United States $0.008B 0.00
Adial Pharmaceuticals (ADIL) United States $0.008B 0.00
Soligenix (SNGX) United States $0.008B 0.00
BioAffinity Technologies (BIAF) United States $0.008B 0.00
Mustang Bio (MBIO) United States $0.008B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.007B 0.00
Artelo Biosciences (ARTL) United States $0.007B 0.00
GENPREX (GNPX) United States $0.007B 0.00
Alzamend Neuro (ALZN) United States $0.007B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
Intensity Therapeutics (INTS) United States $0.007B 0.00
HCW Biologics (HCWB) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Evogene (EVGN) Israel $0.006B 0.00
Apollomics (APLM) United States $0.006B 0.00
Jade Biosciences (JBIO) United States $0.006B 0.00
Polyrizon (PLRZ) Israel $0.006B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.006B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
GT Biopharma (GTBP) United States $0.006B 0.00
Purple Biotech (PPBT) Israel $0.006B 0.00
Tharimmune (THAR) United States $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
BRIACELL THERAP (BCTX) Canada $0.005B 0.00
VivoSim Labs (VIVS) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
Dermata Therapeutics (DRMA) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
CNS Pharmaceuticals (CNSP) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Onconetix (ONCO) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00